|
|
 Previous Article | Table of Contents | Next Article 
Blood, Vol. 90 No. 3 (August 1), 1997:
pp. 929-934
RAPID COMMUNICATION
Activation of p38 MAP Kinase Pathway by Erythropoietin and Interleukin-3
By
Yuka Nagata,
Tetsuo Moriguchi,
Eisuke Nishida, and
Kazuo Todokoro
From the Tsukuba Life Science Center, The Institute of Physical and Chemical Research (RIKEN), Koyadai, Tsukuba, Ibaraki, Japan; and Institute for Virus Research, Kyoto University, Kyoto, Japan.
 |
ABSTRACT |
Activation of p38 MAP kinase (p38) as well as JNK/SAPK has been described as being induced by a variety of environmental stresses such as osmotic shock, ultraviolet radiation, and heat shock, or the proinflammatory cytokines tumor necrosis factor- and interleukin-1 (IL-3). We found that the hematopoietic cytokines erythropoietin (Epo) and IL-3, which regulate growth and differentiation of erythroids and hematopoietic progenitors, respectively, also activate a p38 cascade. Immunoblot analyses and in vitro kinase assay clearly showed that Epo and IL-3 rapidly and transiently phosphorylated and activated p38 in Epo- or IL-3-dependent mouse hematopoietic progenitor cells. p38 can generally be activated by the upstream kinase MKK3 or MKK6. However, in vitro kinase assays in the immunoprecipitates with anti-MKK6 antibody and anti-phosphorylated MKK3/MKK6 antibody showed that activation of neither MKK3 nor MKK6 was detected after Epo or IL-3 stimulation, while osmotic shock clearly induced activation of both MKK3/MKK6 and p38. Together with previous observations, these results suggest that both p38 and JNK cascades play an important role not only in stress and proinflammatory cytokine responses but also in hematopoietic cytokine actions.
| |
INTRODUCTION |
MITOGEN-ACTIVATED protein kinases (MAPKs) form a large family of serine-threonine protein kinases activated by separate cascades conserved through evolution.1 In mammalian cells, four distinct MAPK cascades have been identified: the extracellular signal-regulated kinases (ERKs),2,3 c-Jun amino-terminal kinases (JNKs) or stress-activated protein kinases (SAPKs),4,5 p38 MAP kinase (p38) or cytokine suppressive anti-inflammatory drug binding protein (CSBP),6,7 and Erk5/BMK1.8,9 These cascades have become the prototype for the study of structurally related but functionally distinct pathways.
Detailed studies of the JNK and ERK subgroups of MAPK have led to significant insight into the physiological function of these signaling pathways.10-15 In contrast, the role of the p38 signal transduction pathway is poorly understood.7,16-19 The signal transduction pathway leading to p38 activation is related, in part, to a pathway in yeast leading to activation of a MAPK known as Hog1p. To date the activation of this yeast pathway has been shown to occur principally in response to increased extracellular osmolarity,20 and recently two distinct pathways leading to Hog1p activation have been defined in Saccharomyces cerevisiae.21,22
In mammalian cells p38, the Hog1p homologue, is activated by multiple stimuli acting through different receptors. For example, it was shown that p38 is involved in bacterial endotoxin (lipopolysaccharide)-induced cytokine production through the use of pharmacologic inhibitors that are specific for p38.18 p38 is also activated by other bacterial components, proinflammatory cytokines, and physical-chemical changes in the extracellular environments.19 The contribution of the p38 pathway to the cellular response to these stimuli has not been established. However, recent studies have implicated p38 in the phosphorylation of the small heat shock protein Hsp27,7,16 in increased cytokine expression,18 and in programmed cell death.23 In vitro protein kinase assays showed that p38 phosphorylates MAPKAP kinase-27,16 and the transcription factor ATF-2,19,24 and thus these two proteins have been identified as a substrate of p38.
p38 is activated by at least two dual-specific kinases, MKK324,25 and MKK6,25,26 which phosphorylate on Thr and Tyr residues within Thr-Gly-Tyr motif located in subdomain VIII.19 MKK3 and MKK6 phosphorylate and activate p38 but do not phosphorylate the related JNKs or ERKs24 and, therefore, are specific activators of p38. Recently, it was reported that mixed lineage kinase-3 (MLK-3) can activate the p38 and JNK pathways via MKK3/MKK6 and SEK1.27 Furthermore, the Rho family GTPases Rac1 and Cdc4228-32 and the STE20-related protein kinases PAK-1,32 PAK-3,28 and GC kinase33 have been implicated in the p38 and JNK signaling pathways. However, the other components of the p38 pathway have not been identified.
The p38 and JNK cascades are primarily activated by various environmental stresses: osmotic shock, ultraviolet radiation, heat shock, x-ray radiation, hydrogen peroxide and protein synthesis inhibitors, and by the proinflammatory cytokines tumor necrosis factor- (TNF-) and interleukin-1 (IL-1).7,16-19,34-38 It can also be weakly activated by such mitogenic factors as epidermal growth factor and phorbol esters, and by T-cell activation signaling.39,40 The exact mechanism of how the p38 and JNK cascades integrate with other signaling pathways to achieve specific response to different stimuli remains to be elucidated.
The hematopoietic cytokine receptor-mediated signaling pathways have been extensively studied, and activation of ERK by various hematopoietic cytokines has been evidenced.41-46 We also recently showed that JNK cascade can be activated by hematopoietic cytokines,47 although possible involvement of p38 cascade in hematopoietic cytokine signal transduction has not been determined. Therefore, we examined the possible activation of MKK3/MKK6 and p38 by erythropoietin (Epo) and IL-3, which are hematopoietic cytokines regulating the growth and differentiation of erythroids and hematopoietic progenitors, respectively. Using Epo-dependent FD-EPO cells, which are derived from IL-3-dependent mouse hematopoietic progenitor FDC-P2 cells, we measured the activities of p38 and MKK3/MKK6 after Epo and IL-3 stimulation. We found that Epo and IL-3 induced activation of p38, but could not detect the activation of either MKK3 or MKK6. Taken together with previous observations, these results suggested that p38 as well as JNK cascades represent an important signaling pathway that mediates the actions of hematopoietic cytokines as well, and that hematopoietic cytokines might activate p38 and JNK cascades through a kinase other than MKK3, MKK6, and SEK1/MKK4.
| |
MATERIALS AND METHODS |
Cytokines and antibodies.
Antibody against p38 was obtained from Santa Cruz Biotechnology (Santa Cruz, CA). Rabbit antibodies against Ser189/207-phosphorylated MKK3/MKK6 and against Thr223-phosphorylated SEK1/MKK4 were purchased from New England Biolabs (Beverley, MA). Human Epo (2.6 × 105 U/mg) was a gift of Kirin Brewery (Tokyo, Japan). Mouse IL-3 (1 × 106 U/mg) was obtained from Genzyme (Cambridge, MA). Polyclonal anti-MKK6-specific antibody was prepared as described.48
Cell culture.
Epo-dependent FD-EPO cells, which were derived from IL-3-dependent FDC-P2 cells as previously described,47 were cultured in RPMI 1640 medium supplemented with 10% fetal calf serum (FCS) and 0.5 U/mL of human Epo. FDC-P2 cells were maintained with 500 U/mL of mouse IL-3.
Immunoprecipitation and immunoblotting.
Cells were starved in RPMI 1640 medium containing 0.4% FCS, 0.125 µg/mL of transferrin, and 0.01% bovine serum albumin without Epo or IL-3 for 12 hours, and restimulated with or without 0.5 U/mL of Epo or 500 U/mL of IL-3 for up to 60 minutes. The stimulated and unstimulated cells were immediately lysed in a lysis buffer: 50 mmol/L Tris-HCl, pH 7.5, 0.5% Nonidet P-40 (Calbiochem, La Jolla, CA), 150 mmol/L NaCl, 100 mmol/L sodium fluoride, 10 mmol/L sodium pyrophosphate, 1 mmol/L EDTA, 2 mmol/L Pefabloc (Boehringer Mannheim, Mannheim, Germany), 10 ng/mL leupeptin, and 10 ng/mL aprotinin. Insoluble material was then removed by centrifugation and the precleared cell lysate was incubated with a specific antibody at 4°C for 2 hours. The immunocomplexes were then bound to protein A-Sepharose (Pharmacia, Uppsala, Sweden) at 4°C for 1 hour. The beads were washed five times with lysis buffer containing 0.1% Nonidet P-40 before being boiled in Laemmli sample buffer. Samples were fractionated in 10% sodium dodecyl sulfate (SDS)-polyacrylamide gels and electrotransferred to ECL membrane (Amersham, Buckinghamshire, UK). The membrane was blocked in 5% bovine serum albumin (BSA) in 20 mmol/L Tris-HCl, pH 7.5, 150 mmol/L NaCl, and 0.5% Tween 20 (TBS-T), and incubated with anti-phosphotyrosine antibody or anti-p38 antibody for 2 hours. After washing three times with TBS-T, the membrane was incubated with antimouse or antirabbit IgG conjugated horseradish peroxidase antibody, and the antibody complexes were visualized by an ECL system (Amersham).
Preparation of substrate proteins.
Glutathione-S-transferase (GST)-human ATF-2 fusion protein (amino terminal domain corresponding to amino acids 1 to 96) was obtained from Santa Cruz Biotechnology. His-tagged human p38 in pET28a vector was constructed as described,50 and the plasmid was transfected into BL21(DE3)pLysS. The bacteria grew at OD600 = 0.7 and was incubated with 0.5 mmol/L isopropyl  -D-thiogalactopyranoside for 4 additional hours. Cells were suspended in IMAC-5 (20 mmol/L Tris-HCl, pH 7.9, 500 mmol/L NaCl, 10% glycerol, 5 mmol/L imidazole), and sonicated. To purify the His-p38 protein in the lysates, 1 mL of 50% slurry of His-Bind Resin (Novagen, Madison, WI) was added to 20 mL cell extract and mixed at room temperature for 60 minutes. The His-Bind Resin was washed with 10 vol of IMAC-5, and washed sequentially with 4 vol of each 10% IMAC-200 (20 mmol/L Tris-HCl, pH 7.9, 500 mmol/L NaCl, 10% glycerol, 200 mmol/L imidazole)/90% IMAC-5, 20% IMAC-200/80% IMAC-5, and finally 30% IMAC-200/70% IMAC-5. The bound proteins were eluted with 4 vol of 50% IMAC-200/50% IMAC-5. The amounts of purified fusion proteins were estimated by the method of Bradford.51
In vitro protein kinase assay.
Immunoprecipitates with anti-p38 antibody, anti-MKK6 antibody, or anti-phosphorylated MKK3/MKK6 antibody were mixed with 1 µg of purified substrates, either GST-ATF-2 or His-p38, in 20 µmol/L adenosine triphosphate (ATP) and 5 µCi of [ -32P]ATP in 30 µL of kinase buffer (25 mmol/L HEPES, pH 7.4, 25 mmol/L -glycerophosphate, 25 mmol/L MgCl2 , 0.1 mmol/L sodium orthovanadate, 2 mmol/L dithiothreitol [DTT]), and incubated at 30°C for 30 minutes. The reactions were terminated by mixing with Laemmli sample buffer and boiling. The samples were resolved by 10% SDS-polyacrylamide gel electrophoresis, and autoradiographed.
| |
RESULTS |
p38 was phosphorylated by Epo and IL-3 stimulation.
Possible p38 phosphorylation was examined in Epo-stimulated FD-EPO cells. This cell line expresses endogenous Epo receptors and responds with Epo in a dose-dependent manner. Figure 1A shows the time course of p38 phosphorylation after Epo stimulation. p38 immunoprecipitated with anti-p38-specific antibody was immunoblotted with antiphosphotyrosine antibody 4G10. It was found that p38 was rapidly and transiently tyrosine-phosphorylated by Epo stimulation (Fig 1A, left panel). Little tyrosine-phosphorylated p38 was detected before stimulation, the level of tyrosine-phosphorylation reached the maximum at 15 minutes after Epo stimulation and decreased thereafter (Fig 1A, left panel). The blot was reprobed by the anti-p38 antibody to ensure that equal amounts of p38 were immunoprecipitated during the separation of p38 from the cell lysates (Fig 1A, right panel); it was confirmed that this was the case.
View larger version (42K):
[in this window]
[in a new window]
View larger version (44K):
[in this window]
[in a new window]
| Fig 1.
p38 was phosphorylated by Epo and IL-3 stimulation. p38 was immunoprecipitated at various time points (0 to 60 minutes) in Epo-stimulated FD-EPO cell lysates (A) or IL-3-stimulated FDC-P2 cell lysates (B). The immunoprecipitates were immunoblotted with antiphosphotyrosine antibody 4G10 (left panels) or with p38 antibody (right panels). Arrows indicate the phosphorylated p38 (left panels) and total p38 (right panels).
|
|
Possible p38 phosphorylation was similarly examined in IL-3-stimulated FDC-P2 cells. Figure 1B shows the time course of p38 phosphorylation after IL-3 stimulation; clearly p38 was rapidly and transiently tyrosine-phosphorylated by this stimulation (Fig 1B, left panel). The maximal level of tyrosine-phosphorylation was detected after 15 minutes (Fig 1B, left panel), and it was confirmed that equal amounts of p38 were immunoprecipitated (Fig 1B, right panel).
In vitro kinase assay showed that Epo and IL-3 activate p38.
Next, we examined in vitro p38 activity in the cell lysates after Epo or IL-3 stimulation. The p38 was immunoprecipitated by anti-p38-specific antibody at various time points after Epo or IL-3 stimulation, and the protein kinase activity in the immunoprecipitates was measured in the presence of [-32P]ATP and the purified GST-ATF-2 protein (molecular weight, 40 kD) as a substrate.
As shown in Fig 2, both Epo and IL-3 rapidly and transiently activated p38. p38 activity was rarely seen in unstimulated cells, but a rapid and marked increase in the activity was observed within 5 minutes of treatment with Epo (Fig 2A) or IL-3 (Fig 2B). The activity then reached the maximal level at 15 minutes and decreased thereafter in both cases (Fig 2A and B). Thus, both Epo and IL-3 rapidly and transiently induce phosphorylation and activation of p38.
View larger version (19K):
[in this window]
[in a new window]
| Fig 2.
In vitro p38 activity is induced by Epo and IL-3 stimulation. FD-EPO cells (A) and FDC-P2 cells (B and C) were stimulated with Epo (A) and IL-3 (B), respectively, for the indicated time up to 60 minutes or stimulated with (+) or without (-) NaCl (C) for 30 minutes. The immunoprecipitates with anti-p38-specific antibody were incubated with [-32P]ATP and GST-ATF-2 as a substrate. Arrows indicate the phosphorylated GST-ATF-2 (molecular weight, 40 kD).
|
|
Activation of MKK6 was not detected after Epo or IL-3 stimulation.
It has been reported that MKK3 and MKK6 phosphorylate and activate p38,24 and thus we sought to learn whether or not either of these kinases is indeed activated upon Epo or IL-3 stimulation. The protein kinase activity in the immunoprecipitates with anti-MKK6-specific antibody was measured in the presence of [-32P]ATP and the purified His-p38 as a substrate (Fig 3). His-p38 could phosphorylate itself without the immunoprecipitates (Fig 3A through C, lane C). At various time points after Epo or IL-3 stimulation, the levels of phosphorylated His-p38 did not change but were the same level as lane C (Fig 3A and B); in contrast, MKK6 activity was clearly enhanced by osmotic shock (Fig 3C). Therefore, in these assays we detected no MKK6 activation after Epo or IL-3 stimulation.
View larger version (19K):
[in this window]
[in a new window]
| Fig 3.
In vitro MKK6 assay. FD-EPO cells (A) and FDC-P2 cells (B and C) were stimulated with Epo (A) and IL-3 (B), respectively, for the indicated time up to 60 minutes or stimulated with (+) or without (-) NaCl (C) for 30 minutes. MKK6 activity was measured in the immunoprecipitates with antispecific MKK6 antibody in the presence of [-32P]ATP and His-p38 as a substrate. Lane C, the kinase assay was performed without immunoprecipitates (only His-p38). Arrows indicate the phosphorylated His-p38.
|
|
Similarly, the protein kinase activity in the immunoprecipitates with antiphosphorylated-MKK3/MKK6 antibody was measured with His-p38 as a substrate (Fig 4). This antibody can immunoprecipitate both Ser189-phosphorylated MKK3 and Ser207-phosphorylated MKK6. Once again, the MKK3 and/or MKK6 activities at various time points after Epo or IL-3 stimulation were the same as those without the immunoprecipitates (Fig 4A and B), whereas MKK3 and/or MKK6 activity was clearly induced by osmotic shock (Fig 4C). Because MKK3-specific antibody, which can be used for in vitro protein kinase assay, is not available at present, we used these two antibodies. Although we may not be able to completely eliminate the possibility that Epo and IL-3 weakly activate MKK3 and/or MKK6, it is possible that p38 is activated by a kinase other than these two.
View larger version (18K):
[in this window]
[in a new window]
| Fig 4.
In vitro MKK3/MKK6 assay. FD-EPO cells (A) and FDC-P2 cells (B and C) were stimulated with Epo (A) and IL-3 (B), respectively, for the indicated time up to 60 minutes or stimulated with (+) or without (-) NaCl (C) for 30 minutes. The immunoprecipitates with antiphosphorylated MKK3/MKK6 antibody were incubated in the presence of [-32P] ATP and His-p38 as a substrate. Lane C, the kinase assay was performed without immunoprecipitates (only His-p38). Arrows indicate the phosphorylated His-p38.
|
|
We concluded that hematopoietic cytokines, at least Epo and IL-3, clearly induce activation of p38, though the primary activation may not be by MKK3 or MKK6, and that the p38 signaling pathway plays an important role not only in the response to environmental stresses and proinflammatory cytokines, but also to hematopoietic cytokines.
| |
DISCUSSION |
We showed in this report that hematopoietic cytokines, at least Epo and IL-3, whose receptors belong to the type I cytokine superfamily, clearly activate the p38 signaling pathway, which has heretofore been believed to be activated only by the environmental stresses of osmotic shock, UV radiation and heat shock, or by proinflammatory cytokines like TNF- and IL-1.7,16-19 We also observed that thrombopoietin phosphorylates and activates p38 (data not shown). Hematopoietic cytokines reportedly activate the ERK cascade,41-46 and we recently showed that the JNK cascade is also activated by these cytokines.47 Thus, it appears that hematopoietic cytokines simultaneously activate the entire known MAPK family, ERK cascade, JNK cascade, and p38 cascade.
We observed that p38 was clearly activated by hematopoietic cytokines, but activation of neither MKK3 nor MKK6 was detected after IL-3 and Epo stimulation. It has also been reported that epidermal growth factor and nerve growth factor induced activation of neither MKK324 nor MKK6,52 while p38 was clearly activated.19 Although we may not be able to completely eliminate the possibility that MKK3 and/or MKK6 partially activates p38 in these hematopoietic cytokine-stimulated cells, it is possible that a kinase other than one of these is mainly involved in the activation due to factors such as epidermal growth factor, nerve growth factor, and hematopoietic cytokines.
It was reported that a novel hematopoietic-specific protein kinase, hematopoietic progenitor kinase 1 (HPK1), activates JNK cascade.53 Although ubiquitously expressed MKK3, MKK6, and SEK1/MKK4 may also act as upstream kinases of p38 and JNK cascades in hematopoietic cells, other unidentified hematopoietic-specific kinases may exist that activate p38 and/or JNK cascades in a hematopoietic cytokine-specific manner. The MKK that specifically activates p38 and/or JNK cascades in hematopoietic cells remains to be identified.
Cellular stresses and inflammatory cytokines that activate the p38 and JNK pathways reportedly induce cell death characteristic of apoptosis.54,55 In PC12 cells, dominant-interfering or constitutively activated forms of various components of the p38, JNK, and ERK signaling pathways showed that activation of p38 and JNK and concurrent inhibition of ERK are critical for induction of apoptosis.23 However, TNF--induced apoptosis was not affected by a specific p38 inhibitor SB203580 in L929 cells.56 Dominant negative JNK or SEK1 also did not affect apoptosis in 3T3 cells.57 The targets of hematopoietic cytokine-induced p38 and the JNK signaling pathway, and the role of the p38 and JNK signaling cascade in hematopoietic cytokine actions, ie, cell differentiation, proliferation, tissue-specific functions, inhibition or stimulation of apoptosis and/or cell survival, require clarification.
| |
FOOTNOTES |
Submitted March 24, 1997;
accepted April 29, 1997.
Supported in part by a Special Grant for Promotion of Research from The Institute of Physical and Chemical Research (RIKEN).
Address reprint requests to Kazuo Todokoro, PhD, Tsukuba Life Science Center, The Institute of Physical and Chemical Research (RIKEN), 3-1, Koyadai, Tsukuba, Ibaraki 305, Japan.
The publication costs of this article were defrayed in part by page
charge payment. This article must therefore be hearly marked
``advertisment'' in accordance with 18 U.S.C. section 1734 solely to
indicate this fact.
| |
ACKNOWLEDGMENT |
The authors thank Dr M Hibi (Osaka University, Osaka, Japan) for valuable discussions, Kirin Brewery for Epo, and C. Hisano and I. Mogi for their technical assistance.
| |
REFERENCES |
1.
Neiman AM:
Conservation and reiteration of a kinase cascade.
Trends Genet
9:390,
1993[Medline]
[Order article via Infotrieve]
2.
Boulton TG,
Nye SH,
Robbins DJ,
Ip NY,
Radziejewska E,
Morgenbesser SD,
DePinho RA,
Panayotatos N,
Cobb MH,
Yancopoulos GD:
ERKs: A family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF.
Cell
65:663,
1991[Medline]
[Order article via Infotrieve]
3.
Seger R,
Ahn NG,
Boulton TG,
Yancopoulos GD,
Panayotatos N,
Radziejewska E,
Ericsson L,
Bratlien RL,
Cobb MH,
Krebs EG:
Microtubule-associated protein 2 kinases, ERK1 and ERK2, undergo autophosphorylation on both tyrosine and threonine residues: Implications for their mechanism of activation.
Proc Natl Acad Sci USA
88:6142,
1991[Abstract/Free Full Text]
4.
Kyriakis JM,
Banerjee P,
Nikolakaki E,
Dai T,
Rubie EA,
Ahmad MF,
Avruch J,
Woodgett JR:
The stress-activated protein kinase subfamily of c-Jun kinases.
Nature
369:156,
1994[Medline]
[Order article via Infotrieve]
5.
Derijard B,
Hibi M,
Wu I-H,
Barrett T,
Su B,
Deng T,
Karin M,
Davis RJ:
JNK1: A protein kinase stimulated by UV light and H-Ras that binds and phosphorylates the c-Jun activation domain.
Cell
76:1025,
1994[Medline]
[Order article via Infotrieve]
6.
Han J,
Lee JD,
Bibbs L,
Ulevitch RJ:
A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells.
Science
265:808,
1994[Abstract/Free Full Text]
7.
Rouse J,
Cohen P,
Trigon S,
Morange M,
Alonso-Llamazares A,
Zamanillo D,
Hunt T,
Nebreda AR:
A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins.
Cell
78:1027,
1994[Medline]
[Order article via Infotrieve]
8.
Lee JD,
Ulevitch RJ,
Han J:
Primary structure of BMK1: A new mammalian MAP kinase.
Biochem Biophys Res Commun
213:715,
1995[Medline]
[Order article via Infotrieve]
9.
Zhou G,
Bao ZQ,
Dixon JE:
Components of a new human protein kinase signal transduction pathway.
J Biol Chem
270:12665,
1995[Abstract/Free Full Text]
10.
Blenis J:
Signal transduction via the MAP kinases: Proceed at your own RSK.
Proc Natl Acad Sci USA
90:5889,
1993[Abstract/Free Full Text]
11.
Crews CM,
Erikson RL:
Extracellular signals and reversible protein phosphorylation: What to Mek of it all.
Cell
74:215,
1993[Medline]
[Order article via Infotrieve]
12.
Davis RJ:
The mitogen-activated protein kinase signal transduction pathway.
J Biol Chem
268:14553,
1993[Free Full Text]
13.
Davis RJ:
MAP kinases: New JNK expands the group.
Trends Biochem Sci
19:470,
1994[Medline]
[Order article via Infotrieve]
14.
Marshall CJ:
Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation.
Cell
80:179,
1995[Medline]
[Order article via Infotrieve]
15.
Robbins DJ,
Zhen E,
Cheng M,
Xu S,
Ebert D,
Cobb MH:
MAP kinases ERK1 and ERK2: Pleiotropic enzymes in a ubiquitous signaling network.
Adv Cancer Res
63:93,
1994[Medline]
[Order article via Infotrieve]
16.
Freshney NW,
Rawlinson L,
Guesdon F,
Jones E,
Cowley S,
Hsuan J,
Saklatvala J:
Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27.
Cell
78:1039,
1994[Medline]
[Order article via Infotrieve]
17.
Han J,
Lee JD,
Bibbs L,
Ulevitch RJ:
A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells.
Science
265:808,
1994
18.
Lee JC,
Laydon JT,
McDonnell PC,
Gallagher TF,
Kumar S,
Green D,
McNulty D,
Blumenthal MJ,
Heys JR,
Landvatter SW,
Strickler JE,
McLaughlin MM,
Siemens IR,
Fisher SM,
Livi GP,
White JR,
Adams JL,
Young PR:
A protein kinase involved in the regulation of inflammatory cytokine biosynthesis.
Nature
372:739,
1994[Medline]
[Order article via Infotrieve]
19.
Raingeaud J,
Gupta S,
Rogers J,
Dickens M,
Han J,
Ulevitch RJ,
Davis RJ:
Pro-inflammatory cytokines and environmental stress cause p38 MAP kinase activation by dual phosphorylation on tyrosine and threonine.
J Biol Chem
270:7420,
1995[Abstract/Free Full Text]
20.
Brewster JL,
de Valoir T,
Dyer ND,
Winter E,
Gustin MC:
An osmosensing signal transduction pathway in yeast.
Science
259:1760,
1993[Abstract/Free Full Text]
21.
Maeda T,
Wurgler-Murphy SM,
Saito H:
A two-component system that regulates an osmosensing MAP kinase cascade in yeast.
Nature
369:242,
1994[Medline]
[Order article via Infotrieve]
22.
Maeda T,
Takekawa M,
Saito H:
Activation of yeast PBS2 MAPKK by MAPKKKs or by binding of an SH3-containing osmosensor.
Science
269:554,
1995[Abstract/Free Full Text]
23.
Xia Z,
Dickens M,
Raingeaud J,
Davis RJ,
Greenberg ME:
Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis.
Science
270:1326,
1995[Abstract/Free Full Text]
24.
Derijard B,
Raingeaud J,
Barrett T,
Wu IH,
Han J,
Ulevitch RJ,
Davis RJ:
Independent human MAP kinase signal transduction pathways defined by MEK and MKK isoforms.
Science
267:682,
1995[Abstract/Free Full Text]
25.
Raingeaud J,
Whitmarsh AJ,
Barrett T,
Derijard B,
Davies RJ:
MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway.
Mol Cell Biol
16:1247,
1996[Abstract]
26.
Han J,
Lee JD,
Jiang Y,
Li Z,
Feng L,
Ulevitch RJ:
Characterization of the structure and function of a novel MAP kinase kinase (MKK6).
J Biol Chem
271:2886,
1996[Abstract/Free Full Text]
27.
Tibbles LA,
Ing YL,
Kiefer F,
Chan J,
Iscove N,
Woodgett JR,
Lassam NJ:
MLK-3 activates the SAPK/JNK and p38/RK pathways via SEK1 and MKK3/6.
EMBO J
15:7026,
1996[Medline]
[Order article via Infotrieve]
28.
Bagrodia S,
Derijard B,
Davis RJ,
Cerione R:
Cdc42 and PAK-mediated signaling leads to JNK and p38 MAP kinase activation.
J Biol Chem
270:27995,
1995[Abstract/Free Full Text]
29.
Coso OA,
Chiariello M,
Yu JC,
Teramoto H,
Crespo P,
Xu N,
Miki T,
Gutkind JS:
The small GTP-binding proteins rac1 and cdc42 regulate the activity of the JNK/SAPK signaling pathway.
Cell
81:1137,
1995[Medline]
[Order article via Infotrieve]
30.
Minden A,
Lin A,
Claret FX,
Abo A,
Karin M:
Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and cdc42Hs.
Cell
81:1147,
1995[Medline]
[Order article via Infotrieve]
31.
Olson MF,
Ashworth A,
Hall A:
An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1.
Science
269:1270,
1995[Abstract/Free Full Text]
32.
Zhang S,
Han J,
Sells MA,
Chernoff J,
Knaus UG,
Ulevitch RJ,
Bokoch GM:
Rho family GTPases regulate p38 mitogen-activated protein kinase through the down-stream mediator PAK-1.
J Biol Chem
270:23934,
1995[Abstract/Free Full Text]
33.
Pombo CM,
Kehrl JH,
Sanchez I,
Katz P,
Avruch J,
Zon LI,
Woodgett JR,
Force T,
Kyriakis JM:
Activation of the SAPK pathway by the human STE20 homologue germinal center kinase.
Nature
377:750,
1995[Medline]
[Order article via Infotrieve]
34.
Yan M,
Dai T,
Deak JC,
Kyriakis JM,
Zon LI,
Woodgett JR,
Templeton DJ:
Activation of stress-activated protein kinase by MEKK1 phosphorylation of its activation SEK1.
Nature
372:798,
1994[Medline]
[Order article via Infotrieve]
35.
Sluss HK,
Barrett T,
Derijard B,
Davis RJ:
Signal transduction by tumor necrosis factor mediated by JNK protein kinases.
Mol Cell Biol
14:8376,
1994[Abstract/Free Full Text]
36.
Westwick JK,
Bielawska AE,
Dbaibo G,
Hannun YA,
Brenner DA:
Ceramide activates the stress-activated protein kinases.
J Biol Chem
270:22689,
1995[Abstract/Free Full Text]
37.
Galcheva-Gargova Z,
Derijard B,
Wu IH,
Davis RJ:
An osmosensing signal transduction pathway in mammalian cells.
Science
265:806,
1994[Abstract/Free Full Text]
38.
Verheij M,
Bose R,
Lin XH,
Yao B,
Jarvis WD,
Grant S,
Birrer MJ,
Szabo E,
Zon LI,
Kyriakis JM,
Haimovitz-Friedman A,
Fuks Z,
Kolesnick RN:
Requirement for ceramide-initiated SAPK/JNK signaling in stress-induced apoptosis.
Nature
380:75,
1996[Medline]
[Order article via Infotrieve]
39.
Karin M:
The regulation of AP-1 activation by mitogen-activated protein kinases.
J Biol Chem
270:16483,
1995[Free Full Text]
40.
Su B,
Jacinto E,
Hibi M,
Kallunki T,
Karin M,
Ben-Neriah Y:
JNK is involved in signal integration during costimulation of T lymphocytes.
Cell
77:727,
1994[Medline]
[Order article via Infotrieve]
41.
Satoh T,
Nakafuku M,
Miyajima A,
Kaziro Y:
Involvement of ras p21 protein in signal transduction pathways from interleukin 2, interleukin 3, and granulocyte/macrophage colony-stimulating factor, but not from interleukin 4.
Proc Natl Acad Sci USA
88:3314,
1991[Abstract/Free Full Text]
42.
Torti M,
Marti KB,
Altschuler D,
Yamamoto K,
Lapetina EG:
Erythropoietin induces p21 ras activation and p120GAP tyrosine phosphorylation in human erythroleukemia cells.
J Biol Chem
267:8293,
1992[Abstract/Free Full Text]
43.
Satoh T,
Nakafuku M,
Kaziro Y:
Function of Ras as a molecular switch in signal transduction.
J Biol Chem
267:24149,
1992[Free Full Text]
44.
Sato N,
Sakamaki K,
Terada N,
Arai K,
Miyajima A:
Signal transduction by the high-affinity GM-CSF receptor: Two distinct cytoplasmic regions of the common beta subunit responsible for different signal.
EMBO J
12:4181,
1993[Medline]
[Order article via Infotrieve]
45.
Nagata Y,
Todokoro K:
Thrombopoietin induces activation of at least two distinct signaling pathways.
FEBS Lett
377:497,
1995[Medline]
[Order article via Infotrieve]
46.
Todokoro K,
Sugiyama M,
Nishida E,
Nakaya K:
Activation of mitogen-activated protein kinase cascade through erythropoietin receptor.
Biochem Biophys Res Commun
203:1912,
1994[Medline]
[Order article via Infotrieve]
47.
Nagata Y,
Nishida E,
Todokoro K:
Activation of JNK signaling pathway by erythropoietin, thrombopoietin, and interleukin-3.
Blood
89:2664,
1997[Abstract/Free Full Text]
48.
Moriguchi T,
Toyoshima F,
Gotoh Y,
Iwamatsu A,
Irie K,
Mori E,
Kuroyanagi N,
Hagiwara M,
Matsumoto K,
Nishida E:
Purification and identification of a major activator for p38 from osmotically shocked cells.
J Biol Chem
271:26987,
1996
49.
Nagata Y,
Nagahisa H,
Aida Y,
Okutomi K,
Nagasawa T,
Todokoro K:
Thrombopoietin induces megakaryocyte differentiation in hematopoietic progenitor FDC-P2 cells.
J Biol Chem
270:19673,
1995[Abstract/Free Full Text]
50.
Moriguchi T,
Kuroyanagi N,
Yamaguchi K,
Gotoh Y,
Irie K,
Kano T,
Shirakabe K,
Muro Y,
Shibuya H,
Matsumoto K,
Nishida E,
Hagiwara M:
A novel kinase cascade mediated by mitogen-activated protein kinase kinase 6 and MKK3.
J Biol Chem
271:13675,
1996[Abstract/Free Full Text]
51.
Bradford MM:
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
Anal Biochem
72:248,
1976[Medline]
[Order article via Infotrieve]
52.
Stein B,
Brady H,
Yang MX,
Young DB,
Barbosa MS:
Cloning and characterization of MEK6, a novel member of the mitogen-activated protein kinase cascade.
J Biol Chem
271:11427,
1996[Abstract/Free Full Text]
53.
Kiefer F,
Tibbles LA,
Anafi M,
Janssen A,
Zanke BW,
Lassam N,
Pawson T,
Woodgett JR,
Iscove NN:
HPK1, a hematopoietic protein kinase activating the SAPK/JNK pathway.
EMBO J
15:7013,
1996[Medline]
[Order article via Infotrieve]
54.
Verheij M,
Bose R,
Lin XH,
Yao B,
Jarvis WD,
Grant S,
Birrer MJ,
Szabo E,
Zon LI,
Kyriakis JM,
Haimovitz-Friedman A,
Fuks Z,
Kolesnick RN:
Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis.
Nature
380:75,
1996
55.
Santana P,
Pena LA,
Haimovitz-Friedman A,
Martin S,
Green D,
McLoughlin M,
Cordon-Cardo C,
Schuchman EH,
Fuks Z,
Kolesnick R:
Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in rediation-induced apoptosis.
Cell
86:189,
1996[Medline]
[Order article via Infotrieve]
56.
Beyaert R,
Cuenda A,
Berghe WV,
Plaisance S,
Lee JC,
Haegeman G,
Cohen P,
Fiers W:
The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis in response to tumour necrosis factor.
EMBO J
15:1914,
1996[Medline]
[Order article via Infotrieve]
57.
Johnson NL,
Gardner AM,
Diener KM,
Lange-Carter CA,
Gleavy J,
Jarpe MB,
Minden A,
Karin M,
Zon LI,
Johnson GL:
Signal transduction pathways regulated by mitogen-activated/extracellular response kinase kinase kinase induce cell death.
J Biol Chem
271:3229,
1996[Abstract/Free Full Text]
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
C. R. Geest and P. J. Coffer
MAPK signaling pathways in the regulation of hematopoiesis
J. Leukoc. Biol.,
August 1, 2009;
86(2):
237 - 250.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. A. Dalmas, L. A. Tierney, C. Zhang, P. K. Narayanan, R. W. Boyce, L. W. Schwartz, K. S. Frazier, and M. S. Scicchitano
Effects of p38 MAP Kinase Inhibitors on the Differentiation and Maturation of Erythroid Progenitors
Toxicol Pathol,
December 1, 2008;
36(7):
958 - 971.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. DiMascio, C. Voermans, M. Uqoezwa, A. Duncan, D. Lu, J. Wu, U. Sankar, and T. Reya
Identification of Adiponectin as a Novel Hemopoietic Stem Cell Growth Factor
J. Immunol.,
March 15, 2007;
178(6):
3511 - 3520.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Nishigaki, C. Hanson, D. Thompson, T. Yugawa, and S. Ruscetti
Activation of the Jun N-Terminal Kinase Pathway by Friend Spleen Focus-Forming Virus and Its Role in the Growth and Survival of Friend Virus-Induced Erythroleukemia Cells
J. Virol.,
October 15, 2005;
79(20):
12752 - 12762.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Canfield, Y. Lee, A. Schroder, and P. Rothman
Cutting Edge: IL-4 Induces Suppressor of Cytokine Signaling-3 Expression in B Cells by a Mechanism Dependent on Activation of p38 MAPK
J. Immunol.,
March 1, 2005;
174(5):
2494 - 2498.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. C. Platanias
Map kinase signaling pathways and hematologic malignancies
Blood,
June 15, 2003;
101(12):
4667 - 4679.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Ravandi, M. Talpaz, and Z. Estrov
Modulation of Cellular Signaling Pathways: Prospects for Targeted Therapy in Hematological Malignancies
Clin. Cancer Res.,
February 1, 2003;
9(2):
535 - 550.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Kapur, S. Chandra, R. Cooper, J. McCarthy, and D. A. Williams
Role of p38 and ERK MAP kinase in proliferation of erythroid progenitors in response to stimulation by soluble and membrane isoforms of stem cell factor
Blood,
July 30, 2002;
100(4):
1287 - 1293.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. M.-Y. Ho, M. H.-H. Nguyen, J. K. Dierov, K. M. Badger, B. K. Beattie, P. Tartaro, R. Haq, B. W. Zanke, M. P. Carroll, and D. L. Barber
TEL-JAK2 constitutively activates the extracellular signal-regulated kinase (ERK), stress-activated protein/Jun kinase (SAPK/JNK), and p38 signaling pathways
Blood,
July 30, 2002;
100(4):
1438 - 1448.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.-I. Park, H.-S. Choi, J.-S. Jeong, J.-Y. Han, and I.-H. Kim
Involvement of p38 Kinase in Hydroxyurea-induced Differentiation of K562 Cells
Cell Growth Differ.,
September 1, 2001;
12(9):
481 - 486.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. Kadri, E. Petitfrère, C. Boudot, J.-M. Freyssinier, S. Fichelson, P. Mayeux, H. Emonard, W. Hornebeck, B. Haye, and C. Billat
Erythropoietin Induction of Tissue Inhibitors of Metalloproteinase-1 Expression and Secretion Is Mediated by Mitogen-activated Protein Kinase and Phosphatidylinositol 3-kinase Pathways
Cell Growth Differ.,
November 1, 2000;
11(11):
573 - 580.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
A. E. Lawson, H. Bao, A. Wickrema, S. M. Jacobs-Helber, and S. T. Sawyer
Phosphatase inhibition promotes antiapoptotic but not proliferative signaling pathways in erythropoietin-dependent HCD57 cells
Blood,
September 15, 2000;
96(6):
2084 - 2092.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Visconti, M. Gadina, M. Chiariello, E. H. Chen, L. F. Stancato, J. S. Gutkind, and J. J. O'Shea
Importance of the MKK6/p38 pathway for interleukin-12-induced STAT4 serine phosphorylation and transcriptional activity
Blood,
September 1, 2000;
96(5):
1844 - 1852.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Adachi, B. K. Choudhury, S. Stafford, S. Sur, and R. Alam
The Differential Role of Extracellular Signal-Regulated Kinases and p38 Mitogen-Activated Protein Kinase in Eosinophil Functions
J. Immunol.,
August 15, 2000;
165(4):
2198 - 2204.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. M. Jacobs-Helber, J. J. Ryan, and S. T. Sawyer
JNK and p38 are activated by erythropoietin (EPO) but are not induced in apoptosis following EPO withdrawal in EPO-dependent HCD57 cells
Blood,
August 1, 2000;
96(3):
933 - 940.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. Witt, K. Sand, and A. Pekrun
Butyrate-induced erythroid differentiation of human K562 leukemia cells involves inhibition of ERK and activation of p38 MAP kinase pathways
Blood,
April 1, 2000;
95(7):
2391 - 2396.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Zhu and P. E. Lobie
Janus Kinase 2-dependent Activation of p38 Mitogen-activated Protein Kinase by Growth Hormone. RESULTANT TRANSCRIPTIONAL ACTIVATION OF ATF-2 AND CHOP, CYTOSKELETAL RE-ORGANIZATION AND MITOGENESIS
J. Biol. Chem.,
January 21, 2000;
275(3):
2103 - 2114.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. A. Wadsworth, D. E. Cavender, S. A. Beers, P. Lalan, P. H. Schafer, E. A. Malloy, W. Wu, B. Fahmy, G. C. Olini, J. E. Davis, et al.
RWJ 67657, a Potent, Orally Active Inhibitor of p38 Mitogen-Activated Protein Kinase
J. Pharmacol. Exp. Ther.,
November 1, 1999;
291(2):
680 - 687.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
T. B. van Dijk, B. Baltus, J. A. M. Raaijmakers, J.-W. J. Lammers, L. Koenderman, and R. P. de Groot
A Composite C/EBP Binding Site Is Essential for the Activity of the Promoter of the IL-3/IL-5/Granulocyte-Macrophage Colony-Stimulating Factor Receptor {beta}c Gene
J. Immunol.,
September 1, 1999;
163(5):
2674 - 2680.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Nagata and K. Todokoro
Requirement of Activation of JNK and p38 for Environmental Stress-Induced Erythroid Differentiation and Apoptosis and of Inhibition of ERK for Apoptosis
Blood,
August 1, 1999;
94(3):
853 - 863.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Nagata, F. Kiefer, T. Watanabe, and K. Todokoro
Activation of Hematopoietic Progenitor Kinase-1 by Erythropoietin
Blood,
May 15, 1999;
93(10):
3347 - 3354.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Suzuki, M. Hino, F. Hato, N. Tatsumi, and S. Kitagawa
Cytokine-Specific Activation of Distinct Mitogen-Activated Protein Kinase Subtype Cascades in Human Neutrophils Stimulated by Granulocyte Colony-Stimulating Factor, Granulocyte-Macrophage Colony-Stimulating Factor, and Tumor Necrosis Factor-alpha
Blood,
January 1, 1999;
93(1):
341 - 349.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Nagata, N. Takahashi, R. J. Davis, and K. Todokoro
Activation of p38 MAP Kinase and JNK But Not ERK Is Required for Erythropoietin-Induced Erythroid Differentiation
Blood,
September 15, 1998;
92(6):
1859 - 1869.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Adachi and R. Alam
The mechanism of IL-5 signal transduction
Am J Physiol Cell Physiol,
September 1, 1998;
275(3):
C623 - C633.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
Abstract
Introduction
Abstract